Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2000 participants.
Also called NCT07022587
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,000 participants
- Sponsor
- Registry
-
NCT07022587
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07022587. Randomized; single masking; primary purpose treatment. Start 2025-12-20 (actual); primary completion 2030-12-20 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions
- Acronym
- REC-CAGEFREE Ⅳ
- Condition
- De Novo Stenosis
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Sirolimus-eluting bioresorbable scaffolds
- Intervention (Device)
- Sirolimus-eluting stents
- Lead sponsor
- Xijing Hospital
Record details
- Record id
cardio:ct-nct07022587- Content hash
61bdefdd57a4634931b3285e2a51d2a40677253f4c99b81552bdcb2f415870a9